Format

Send to

Choose Destination
See comment in PubMed Commons below
Curr Top Microbiol Immunol. 2013;364:197-218. doi: 10.1007/978-3-642-33570-9_10.

Structure-based drug discovery for botulinum neurotoxins.

Author information

1
Biology Department, Brookhaven National Laboratory, Upton, NY 11973, USA. swami@bnl.gov

Abstract

Clostridium botulinum neurotoxin is the most poisonous substance known to humans. It is a potential biowarfare threat and a public health hazard. The only therapeutics available is antibody treatment which will not be effective for post-exposure therapy. There are no drugs available for post-intoxication treatment. Accordingly, it is imperative to develop effective drugs to counter botulism. Available structural information on botulinum neurotoxins both alone and in complex with their substrates offers an efficient method for designing structure-based drugs to treat botulism.

PMID:
23239355
DOI:
10.1007/978-3-642-33570-9_10
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Support Center